Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia

被引:90
作者
Reglodi, D
Tamás, A
Somogyvári-Vigh, A
Szántó, Z
Kertes, E
Lénárd, L
Arimura, A
Lengvári, I
机构
[1] Univ Pecs, Hungarian Acad Sci, Neuroendocrinol Res Grp, Dept Anat, Pecs, Hungary
[2] Tulane Univ, Hebert Ctr, US Japan Biomed Res Labs, Dept Med, New Orleans, LA 70118 USA
[3] Univ Pecs, Dept Expt Surg, Pecs, Hungary
[4] Univ Pecs, Hungarian Acad Sci, Neurophysiol Res Grp, Dept Physiol, Pecs, Hungary
关键词
permanent focal cerebral ischemia; neuroprotection; rat; neuropeptides; PACAP;
D O I
10.1016/S0196-9781(02)00262-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PACAP exerts neuroprotective effects under various neurotoxic conditions in vitro. In vivo, it reduces brain damage after global and transient focal ischemia. The present study investigated whether PACAP has neuroprotective effects when applied before the onset of permanent ischemia. Rats were given bolus injections of PACAP38 intracerebroventricularly, and then underwent permanent middle cerebral artery occlusion. The results show that 2 mug of PACAP significantly reduced the infarct size measured 12 and 24 h after the onset of ischemia. No further reduction was obtained by a 7-day pretreatment. PACAP also ameliorated certain sensorimotor deficits. Our present study provides further evidence for the neuroprotective effects of PACAP, and implies that it might be a promising preventive therapeutic agent in ameliorating ischemic brain damage. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:2227 / 2234
页数:8
相关论文
共 48 条
[1]   VASORELAXANT EFFECT OF PACAP-27 ON CANINE CEREBRAL-ARTERIES AND RAT INTRACEREBRAL ARTERIOLES [J].
ANZAI, M ;
SUZUKI, Y ;
TAKAYASU, M ;
KAJITA, Y ;
MORI, Y ;
SEKI, Y ;
SAITO, K ;
SHIBUYA, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 285 (02) :173-179
[2]   Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems [J].
Arimura, A .
JAPANESE JOURNAL OF PHYSIOLOGY, 1998, 48 (05) :301-331
[3]   RAT MIDDLE CEREBRAL-ARTERY OCCLUSION - EVALUATION OF THE MODEL AND DEVELOPMENT OF A NEUROLOGIC EXAMINATION [J].
BEDERSON, JB ;
PITTS, LH ;
TSUJI, M ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, H .
STROKE, 1986, 17 (03) :472-476
[4]   Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats [J].
Campbell, CA ;
Mackay, KB ;
Patel, S ;
King, PD ;
Stretton, JL ;
Hadingham, SJ ;
Hamilton, TC .
EXPERIMENTAL NEUROLOGY, 1997, 148 (01) :45-50
[5]  
Delgado M, 1999, J IMMUNOL, V162, P2358
[6]  
DIMAGL U, 1989, J CEREB BLOOD FLOW M, V9, P589
[7]   PRETREATMENT AND POSTTREATMENT WITH MK-801 BUT NOT PRETREATMENT ALONE REDUCES NEOCORTICAL DAMAGE AFTER FOCAL CEREBRAL-ISCHEMIA IN THE RAT [J].
DIRNAGL, U ;
TANABE, J ;
PULSINELLI, W .
BRAIN RESEARCH, 1990, 527 (01) :62-68
[8]   Duration of neuroprotective treatment for ischemic stroke [J].
Dyker, AG ;
Lees, KR .
STROKE, 1998, 29 (02) :535-542
[9]   Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism [J].
Figiel, M ;
Engele, J .
JOURNAL OF NEUROSCIENCE, 2000, 20 (10) :3596-3605
[10]   BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons [J].
Frechilla, D ;
García-Osta, A ;
Palacios, S ;
Cenarruzabeitia, E ;
Del Río, J .
NEUROREPORT, 2001, 12 (05) :919-923